Epithalon
Research OnlyA synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Russian scientist Vladimir Khavinson, claimed to activate telomerase and extend lifespan. 2025 independent Western research confirmed telomerase activation in vitro. Still not approved anywhere; no controlled human clinical trials.
Epitalon · Epithalone · AGAG · AEDG peptide
5 human studies
- Preclinical
- 54%
- Clinical
- 18%
Based on 28 cited sources
community-reported · not clinically demonstrated · very-low confidence
Demonstrated effect magnitude — not a recommendation or safety claim.
Research Depth 29 (1A 12, 1B 5, 1C 2, 1D 3, 1E 7): best human evidence is uncontrolled ex-vivo lymphocyte chromatin work in senile subjects (15085253, 14647006) plus clinical observations cited in the Khavinson review (12374906) — documented clinical observation tier, no controlled human trials, high RoB, small N, surrogate/indirect outcomes; offset by a substantial multi-model preclinical program (Drosophila 11087911/11182832, CBA mice 11227856, rhesus monkeys 14743609, human fibroblasts 12937682, plus a 2025 Brunel UK in-vitro replication). Mechanism 66 (2A 30, 2B 20, 2C 7, 2D 9): hTERT/telomerase target with measured activity and functional telomere elongation (12937682) but no knockout/antagonist abolition; pathway characterized to the proximal effect; weak/absent dose-response (11087911 found lifespan gain independent of dose); confirmed in in-vivo mammals. Plausibility 64 (3A 24, 3B 20, 3C 12, 3D 8): mechanism->surrogate (telomere elongation) established but surrogate->human anti-aging benefit inferred only; coherent with telomere/aging biology with an ALT-in-cancer safety tension; analogous telomerase activators support the class; claim is moderately broad (telomere + pineal/melatonin + antioxidant + longevity). Global Coverage 44 (4A 18, 4B 11, 4C 15, 4D 0): ~95% from one St. Petersburg institute, single fully-independent UK replication (2025) plus a 2026 China senolytic study, ~28 studies, no regulatory recognition anywhere. Community Experience 70 (5A 22, 5B 24, 5C 13, 5D 11): broad longevity/ biohacker discussion sustained >7 years, broadly consistent sleep/wellbeing themes, no recurring serious adverse signal (absence of signal is not proof of safety). Effectiveness basis community-reported (capped 50, very-low): no quantified human efficacy estimate exists; CR1 10 + CR2 10 + CR3 7 = 27 from consistent but self-selected anecdotal reports of sleep/energy benefit.
The proposed mechanisms of Epithalon are based primarily on Russian research with recent independent in vitro validation in 2025. Human mechanistic data from controlled trials is lacking.
How It Works (Simplified)
Epithalon targets cellular aging through telomere maintenance and related pathways:
Upregulates hTERT gene transcription, leading to increased telomerase enzyme production that maintains and extends telomere length.
Interacts with histone proteins to decondense heterochromatin, potentially reactivating genes that become silenced with age.
Stimulates pineal gland function and melatonin synthesis, which typically decline with age, affecting sleep and circadian rhythms.
Increases activity of protective enzymes like SOD and glutathione peroxidase, reducing oxidative damage to cells and DNA.
Key Research: Al-Dulaimi et al. (Brunel University London, UK, 2025) provided first independent Western confirmation of telomerase and hTERT upregulation with telomere elongation in normal human cells. PMC12411320
Important Limitations
- ~95% of research from single institute (St. Petersburg Institute of Bioregulation and Gerontology)
- 2025 independent replication confirms in vitro effects only - no human clinical validation
- Translation from cell culture to whole-body anti-aging effects is unconfirmed
- ALT (alternative lengthening of telomeres) pathway activation in cancer cells raises safety questions
- Pharmacokinetics, optimal dosing, and bioavailability in humans not characterized
- No controlled human clinical trials have demonstrated any anti-aging benefits
Reported positives
- Improved sleep quality and circadian rhythm reported
- Subjective improvements in energy and wellbeing
- Theoretical longevity benefits from telomerase activation
- Well-tolerated with minimal reported side effects
Reported negatives
- Effects highly subjective and difficult to verify
- No Western clinical trials to confirm benefits
- Expensive for unproven longevity claims
- Product purity concerns from research suppliers
“Popular in longevity and biohacker communities. Claims often exceed available evidence.”
Self-reported, unverified accounts — not clinical evidence and no substitute for the cited research. Anecdotes are prone to selection bias and placebo effects.
Based on preclinical data: Initial effects on gene expression may begin. In vitro studies show hTERT upregulation within days of treatment. Melatonin effects in animal models observed early in treatment.
PMID:12937682Continued treatment in cell culture shows progressive telomere effects. Chromatin remodeling and epigenetic changes may develop. Pineal function restoration observed in animal models within weeks.
PMID:40908429Extended cellular replicative capacity observed in fibroblast cultures. Animal studies typically used treatment periods of several weeks. Antioxidant enzyme upregulation reported.
PMID:12937682Long-term effects are based on animal lifespan studies. Russian protocols often involve cyclical treatment (10-20 days on, rest periods). Human pharmacokinetics and optimal duration are unknown.
Research-based observations
This timeline reflects observations from published clinical and preclinical studies. Individual responses may vary significantly. This is not a guarantee of effects or a dosing schedule. Consult qualified healthcare providers for personalized guidance.
Good Signs (7 indicators)
Warning Signs (5 indicators)
Bad Signs (7 indicators)
For Research Evaluation Only
These quality indicators are general guidelines based on typical peptide characteristics. Professional laboratory testing (HPLC, mass spectrometry) provides definitive quality verification. This checklist is for initial visual evaluation only.
Thymosin-Alpha-1
CompatibleBoth developed within Russian peptide bioregulation research - epithalon for telomerase activation, Ta1 for immune modulation. No known direct interactions.
GHK-Cu
CompatibleDifferent anti-aging mechanisms may be complementary - GHK-Cu modulates gene expression for tissue repair, epithalon targets telomere maintenance.
Selank
CompatibleBoth Russian bioregulator peptides with distinct targets - epithalon for pineal/longevity, Selank for anxiolytic effects via GABA modulation.
Semax
CompatibleBoth Russian nootropic-class peptides - Semax provides acute neuroprotection via BDNF, epithalon targets longer-term telomere effects.
BPC-157
CompatibleDifferent regenerative targets - BPC-157 for tissue healing, epithalon for cellular longevity. No known contraindications in combination.
Research Note: Interaction data is based on published literature, mechanistic understanding, and theoretical considerations. Most peptide combinations lack direct clinical study. This information is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare providers.
Key Studies Cited
Full reference list available on request. All citations link to PubMed for verification.
This dossier synthesizes available evidence from peer-reviewed literature, regulatory documents, and clinical trial registries. Evidence strength ratings follow a modified GRADE approach.
For complete methodology details, see our Methodology page.
Important Disclaimer
This dossier is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.
Get Research Alerts
New dossiers and major study summaries delivered to your inbox. Evidence-graded, citation-backed research you can trust.
No spam. Unsubscribe anytime.
Compare Epithalon
Related Peptides
Endoluten
Pineal cytamin · Pineal gland peptides · A-8 pineal peptides
A cytamin-class peptide supplement derived from pineal gland tissue, part of the Russian bioregulator framework. Marketed as an oral supplement for pineal function and melatonin support. Contains peptide complexes rather than defined sequences. No Western clinical validation.
FOXO4-DRI
FOXO4-D-Retro-Inverso · FOXO4-DRI Peptide · Proxofim
A D-retro-inverso peptide designed to disrupt the FOXO4-p53 interaction, selectively eliminating senescent cells (senolytic). Preclinical studies in aged mice demonstrated restored fitness, fur density, and renal function. No human clinical trials conducted. More selective than BCL-2 inhibitors but remains unproven in humans.
Glutathione
GSH · L-Glutathione · Reduced Glutathione +1
The master antioxidant and most abundant intracellular thiol in mammalian cells. This naturally occurring tripeptide (glutamate-cysteine-glycine) is essential for detoxification, immune function, and cellular protection. Extensively studied with strong mechanistic understanding and growing clinical evidence.
Humanin
HN · HNG · S14G-Humanin +2
A 24-amino acid mitochondria-derived peptide (MDP) discovered in 2001 that shows cytoprotective, anti-apoptotic, and neuroprotective effects in preclinical studies. Represents a novel class of signaling molecules encoded within mitochondrial DNA. Extensive academic research with emerging interest in aging, metabolic disease, and neurodegeneration, but no approved clinical applications.
Klotho
Alpha-Klotho · KL protein · Anti-aging protein
An anti-aging transmembrane protein linked to longevity in animal models. Mouse studies demonstrate 15-20% lifespan extension. Primate cognition data published in Nature Aging. Klotho Neurosciences developing therapeutic applications for neurodegenerative disease.
MOTS-c
Mitochondrial ORF of the 12S rRNA type-c · Mitochondrial-derived peptide · MOTS-C peptide
A 16-amino acid mitochondrial-derived peptide encoded in mtDNA that targets AMPK/mTOR pathways for metabolic regulation. Preclinical studies show exercise mimetic and geroprotective effects. Lower MOTS-c levels found in T2D patients. No clinical trials yet conducted in humans.
Related Content
Thymalin
Immune · moderate evidence
Cortexin
Cognitive · moderate evidence
Vilon
Immune · low evidence
What is Epithalon?
An introduction to epithalon, a synthetic tetrapeptide studi...
Bronchogen vs Epithalon
View side-by-side analysis
Cardiogen vs Epithalon
View side-by-side analysis